PTC Therapeutics (NASDAQ:PTCT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
PTC Therapeutics missed estimated earnings by 60.15%, reporting an EPS of $-2.13 versus an estimate of $-1.33.
Revenue was up $48.85 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.27 which was followed by a 2.66% increase in the share price the next day.
Here's a look at PTC Therapeutics's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.51 | -1.64 | -1.40 | -1.82 |
| EPS Actual | -1.78 | -2.03 | -1.89 | -1.68 |
| Revenue Estimate | 147.06M | 150.83M | 126.44M | 110.50M |
| Revenue Actual | 148.74M | 165.23M | 138.74M | 116.68M |
To track all earnings releases for PTC Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
